Assessing susceptibility to vascular disorders
AssigneeUniversity of Iowa Research Foundation
InventorGregory S. Hageman
Life of this patent
Estimating the term…
Abstract
The invention provides methods and reagents for determination of risk and treatment of a vascular disorder such as abdominal aortic aneurysm (AAA) by detecting presence of gene polymorphisms and/or genetic profiles associated with an elevated or a reduced risk of the disorder. In an embodiment, the present invention provides methods and reagents for determining sequence variants in the genome of an individual which facilitate assessment of risk for developing such diseases.
Claims7
A method of determining an individual's risk of abdominal aortic aneurysm(AAA) or a AAA-associated vascular disorder comprising screening the genome of the individual for the presence or absence of a genetic profile characterized by at least one polymorphism selected from Table 1A and/or Table 2A associated with increased risk for or protection against AAA, wherein the presence of a said genetic profile is indicative of the individual's relative risk of AAA.
4-21. (canceled)
A method for treating AAA, the method comprising (i) identifying an individual as having a genetic profile characterized by polymorphisms indicative of risk for developing AAA, wherein the genetic profile comprises at least one polymorphism selected from Table 1A or Table 2A, and (ii) treating the individual.
A kit for determining an individual's risk of abdominal aortic aneurysm (AAA) or an AAA-associated vascular disorder in a human subject, the kit comprising reagents for screening, in a sample from the subject, for the presence or absence of a genetic profile in the genome of the subject characterized by at least one polymorphism selected from Table 1A and/or Table 2A associated with increased risk for or protection against AAA, wherein the presence of a said genetic profile is indicative of the individual's relative risk of AAA.
Dependencies are inferred from the claim text.